Macquarie Group LTD Legend Biotech Corp Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Legend Biotech Corp stock. As of the latest transaction made, Macquarie Group LTD holds 6,887 shares of LEGN stock, worth $305,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,887
Previous 6,887 -0.0%
Holding current value
$305,507
Previous $386,000 20.98%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$57.25 - $69.74 $73,451 - $89,476
1,283 Added 22.89%
6,887 $414,000
Q3 2023

Nov 14, 2023
BUY
$63.16 - $76.5 $44,969 - $54,468
712 Added 14.55%
5,604 $376,000
Q1 2023

May 15, 2023
BUY
$43.42 - $57.37 $84,278 - $111,355
1,941 Added 65.77%
4,892 $235,000
Q3 2022

Nov 14, 2022
BUY
$38.15 - $57.1 $49,518 - $74,115
1,298 Added 78.52%
2,951 $121,000
Q2 2022

Aug 15, 2022
SELL
$33.54 - $55.0 $35,284 - $57,860
-1,052 Reduced 38.89%
1,653 $91,000
Q4 2021

Feb 11, 2022
BUY
$41.14 - $56.98 $108,527 - $150,313
2,638 Added 3937.31%
2,705 $126,000
Q4 2020

Feb 16, 2021
BUY
$25.8 - $32.39 $25 - $32
1 Added 1.52%
67 $2,000
Q3 2020

Nov 13, 2020
SELL
$27.5 - $39.61 $21,972 - $31,648
-799 Reduced 92.37%
66 $2,000
Q2 2020

Aug 11, 2020
BUY
$36.1 - $42.56 $31,226 - $36,814
865 New
865 $37,000

Others Institutions Holding LEGN

# of Institutions
201
Shares Held
74.3M
Call Options Held
374K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.43B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email